4.8 Review

Pharmacologic agents targeting autophagy

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 125, Issue 1, Pages 5-13

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI73937

Keywords

-

Funding

  1. National Institute of Neurological Disorders and Stroke [1R01NS082257]
  2. National Institute on Aging [R37 AG012859]
  3. Ellison Foundation
  4. Ake Wibergs Foundation
  5. Lars Hiertas Memorial Foundation
  6. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082257] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE ON AGING [R37AG012859, R01AG012859] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Autophagy is an important intracellular catabolic mechanism critically involved in regulating tissue homeostasis. The implication of autophagy in human diseases and the need to understand its regulatory mechanisms in mammalian cells have stimulated research efforts that led to the development of high-throughput screening protocols and small-molecule modulators that can activate or inhibit autophagy. Herein we review the current landscape in the development of screening technology as well as the molecules and pharmacologic agents targeting the regulatory mechanisms of autophagy. We also evaluate the potential therapeutic application of these compounds in different human pathologies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available